AIHealthcare

HeartFlow, Inc. is a publicly traded medical technology company specializing in **AI-powered, non-invasive coronary artery disease (CAD) diagnostics and management**. Its HeartFlow One platform uses artificial intelligence and advanced computational fluid dynamics to convert coronary CT angiography (CCTA) scans into personalized 3D models of the heart, enabling functional assessment of blood flow, stenosis, and plaque volume/composition without invasive procedures. HeartFlow’s flagship products include HeartFlow FFRCT Analysis, Plaque Analysis, and RoadMap Analysis, which together provide precision coronary care across the guideline-directed CTA pathway and are widely adopted in hospitals for earlier, more accurate CAD diagnosis and treatment planning. Recognized as a leader in AI-driven CAD management and one of the most widely adopted AI solutions in U.S. healthcare, the company listed on Nasdaq under the ticker HTFL following a 2025 IPO, reinforcing its strong market position in cardiovascular imaging AI.